Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical effects of raloxifene hydrochloride in women.
Khovidhunkit W, Shoback DM. Khovidhunkit W, et al. Among authors: shoback dm. Ann Intern Med. 1999 Mar 2;130(5):431-9. doi: 10.7326/0003-4819-130-5-199903020-00015. Ann Intern Med. 1999. PMID: 10068418 Free article. Review.
Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).
Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM. Schafer AL, et al. J Clin Endocrinol Metab. 2011 Dec;96(12):E1982-9. doi: 10.1210/jc.2011-0587. Epub 2011 Oct 12. J Clin Endocrinol Metab. 2011. PMID: 21994958 Free PMC article. Clinical Trial.
Benefits and risks of bisphosphonate therapy for osteoporosis.
Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT. Khosla S, et al. Among authors: shoback d. J Clin Endocrinol Metab. 2012 Jul;97(7):2272-82. doi: 10.1210/jc.2012-1027. Epub 2012 Apr 20. J Clin Endocrinol Metab. 2012. PMID: 22523337 Review.
Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial.
Schafer AL, Sellmeyer DE, Palermo L, Hietpas J, Eastell R, Shoback DM, Black DM. Schafer AL, et al. J Clin Endocrinol Metab. 2012 Oct;97(10):3522-9. doi: 10.1210/jc.2012-1844. Epub 2012 Jul 12. J Clin Endocrinol Metab. 2012. PMID: 22791766 Free PMC article. Clinical Trial.
Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS).
Schafer AL, Burghardt AJ, Sellmeyer DE, Palermo L, Shoback DM, Majumdar S, Black DM. Schafer AL, et al. Among authors: shoback dm. Osteoporos Int. 2013 Oct;24(10):2591-601. doi: 10.1007/s00198-013-2349-y. Epub 2013 Apr 16. Osteoporos Int. 2013. PMID: 23589163 Clinical Trial.
146 results